World Sight Day: Learn More About “Avoidable Blindness” and Schedule a Comprehensive Eye Examination

World Sight Day is an international “day of awareness,” coordinated by the International Agency for the Prevention of Blindness (IAPB). The purpose of World Site Day is to focus attention on the global issue of avoidable blindness and visual impairment. It is held each year on the second Thursday of October. This year, World Sight … Continued

My Impressions of the Orbit Reader 20

Editor’s note: Recently, Steve Kelley wrote The Holy Grail of Braille and discussed exciting new refreshable braille technology including the Orbit Reader 20. Peer Advisor Sandra Burgess has been part of the testing program of that device and tells us about her experience in this informative post. Efforts to Make Braille More Affordable Braille is … Continued

Low-Cost Refreshable Braille at CSUN

CSUN, the annual Assistive Technology Conference, took place this month in sunny San Diego, and again, I participated "virtually," listening to podcasts and reading tweets of the products featured in between shoveling out from a series of late winter storms in southern Maine! For readers unfamiliar, CSUN is often a conference where new products, updates, … Continued

Stem Cell Treatments for Dry Macular Degeneration—Cautious Optimism Advised for Patients

Treatments for Dry Macular Degeneration: An Unmet Need Age-Related Macular Degeneration (AMD) is the leading cause of legal blindness in Americans over 65. There are two distinct types of the disease, both of which result in the deterioration of the macula, the central part of the retina that allows a person to see fine detail. … Continued

Stem Cell Treatments for Dry Macular Degeneration—Cautious Optimism Advised for Patients

Treatments for Dry Macular Degeneration: An Unmet Need Age-Related Macular Degeneration (AMD) is the leading cause of legal blindness in Americans over 65. There are two distinct types of the disease, both of which result in the deterioration of the macula, the central part of the retina that allows a person to see fine detail. … Continued

Two New Glaucoma Medications to Enter Market in Early 2018

Editor’s note: January is National Glaucoma Awareness Month, and VisionAware is bringing you critical information about management of this serious eye condition. Glaucoma is a diverse group of eye diseases that leads to a characteristic form of damage to the optic nerve. Elevated eye pressure is the primary known risk factor for glaucoma nerve damage … Continued

Is It Possible to Prevent the Inflammation that Triggers Dry Macular Degeneration? New Research Says Maybe

One of the most significant challenges facing eye and vision researchers is developing an effective treatment for dry age-related macular degeneration (AMD). Although there are now a number of well-regarded FDA-approved drug treatments for wet AMD, the key to effective dry AMD treatment remains elusive, although several potential treatments have emerged in recent years. Current … Continued

From Lighthouse Guild: A New Vision Rehabilitation eLearning Program Specifically for Ophthalmologists

Low vision and blindness affect a substantial portion of the older adult population in the United States. Although new research from Johns Hopkins University School of Medicine indicates that the annual number of new cases of blindness and low vision among people aged 45 years and older is estimated to double during the next 30 … Continued

November Is Diabetic Eye Disease Awareness Month: Learn More About Diabetes and Your Eyes

November is Diabetic Eye Disease Awareness Month, which aims to increase awareness of diabetes and diabetic eye disease and encourage people with diabetes to seek treatment for vision problems related to diabetes. You can learn more about diabetes at What Is Diabetes? and ¿Qué es la diabetes? at VisionAware. According to Prevent Blindness America, diabetes … Continued

New Research: The Number of New Cases of Low Vision and Blindness in Adults and Older Adults Is Expected to Double During the Next 30 Years

New research from Johns Hopkins University School of Medicine reveals that the annual number of new cases of blindness and low vision among people aged 45 years and older is estimated to double during the next 30 years. Because data about the incidence of blindness and low vision in the United States was formally estimated … Continued